Uncategorized

Filter posts by category

Tebentafusp update

Groundbreaking Treatment for Metastatic Uveal Melanoma Approved for use in the UK Ocular Melanoma UK (OMUK), formerly known as OcuMel UK, celebrates the landmark announcement that Tebentafusp, a pioneering treatment for metastatic uveal melanoma, is now available to patients in the UK. This approval represents a historic breakthrough, offering renewed hope to people living with

Tebentafusp update Read More »